v3.26.1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Oct. 27, 2025
Oct. 02, 2024
Jul. 14, 2023
Jun. 30, 2023
Jan. 31, 2020
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2026
Commitments and Contingencies                
Non-cancelable commitments for product manufacturing and supply costs               $ 58,100
Vectura License Agreement                
Commitments and Contingencies                
Upfront license fee           $ 2,000    
Maximum potential development milestone payments $ 12,000              
Maximum potential sales milestones $ 92,500              
Pharmosa License Agreement                
Commitments and Contingencies                
Maximum potential development milestone payments   $ 37,750            
Upfront license fee paid       $ 10,000     $ 3,500  
Milestone payment for each additional indication approved by the FDA   10,000            
Milestone payment for each additional indication approved by the EMA   2,000            
Milestone payment for each additional indication approved by the PMDA   500            
Pharmosa License Agreement | North America                
Commitments and Contingencies                
Maximum potential sales milestones   185,000            
Pharmosa License Agreement | Other then North America                
Commitments and Contingencies                
Maximum potential sales milestones   $ 150,000            
Agreement With LGM Pharma, LLC                
Commitments and Contingencies                
Purchase Commitment, Remaining Minimum Amount Committed         $ 2,700      
Expiration term of agreement         5 years      
Amended and Restated Commercial Manufacturing Services and Supply Agreement with Lonza Tampa LLC                
Commitments and Contingencies                
Term of submission     24 months          
Initial term     12 months